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progressive stenosis in those with spastic and dystonic CP, at
no common cervical level, and at GMFCS levels I -III.
Conclusions: New neurologic findings or changes in
function in people with CP must be fully investigated and
cannot be explained as progression of their CP. Even minor
changes noted on scans can result in functional changes in
those with already existing impairments in motor control.
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Patients or Programs: Patient 1, a 35-month-old girl,
former 30.5-week-old preemie, with spastic diplegic cerebral
palsy. Patient 2, a 25-month-old girl with congenital brain
malformation and left spastic hemiparesis.
Program Description: Both children underwent Ona-
botulinumtoxinA (obtx-A) motor point blocks of gastroc-
nemii muscles for management of spasticity. Patient 1 had
bilateral gastrocnemii injected, whereas patient 2 just the left.
Both subjects received a total of 50 units of obtx-A. Patient 1
weighed 10.8 kg, and patient 2 weighed 12.2 kg. Within 24
hours, patient 1 developed new onset status epilepticus.
Patient 2 had a seizure 4 days after the injection.
Setting: University tertiary care pediatric hospital.
Results: Both patients were placed on long-term antiepilep-
tic drugs.
Discussion: Obtx-A is commonly used to treat spasticity in
children with cerebral palsy. It is generally thought to have a
good side-effect profile, though the FDA has recently re-
quired a Black Box warning. There is evidence that obtx-A
may have central side effects. Research suggests that Obtx-A
may affect spinal cord circuitry, the brainstem, and the motor
cortex. There are several proposed mechanisms by which
these central circuits are affected, including blocking gamma
motor endings and reducing spindle afferent input from the
treated muscle, plastic changes at both the level of the motor
neuron and muscle, and retrograde transport and transcyto-
sis. Central nervous system disruptions may potentially
lower seizure threshold, especially in children with underly-
ing risk factors for epilepsy. Seizures have been reported after
obtx-A injections, however, this has been poorly docu-
mented. The above 2 cases developed seizures shortly after
their injections. This raises concern that obtx-A may increase
risk of seizures in children receiving obtx-A injections.
Conclusions: Obtx-A motor point blocks may increase
risk of seizure in children at risk for seizures.
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Patients or Programs: A 13-month-old boy with spastic
quadriplegic cerebral palsy (CP) secondary to shaken baby
syndrome (SBS) seen in the Physical Medicine and Rehabili-
tation (PM&R) clinic for developmental delays and spasticity
management.
Program Description: The patient had developmental
delays, vision impairments, spastic quadriplegia, and dys-
phagia due to shaken baby syndrome. Botulinum toxin A and
clonazepam were initiated to control spasticity and oral ba-
clofen was added later. He received physical and occupa-
tional therapies. Multiple modified barium swallow studies
(MBS) were performed revealing dysphagia requiring no oral
intake. To further control spasticity, at age 2, he underwent
an intrathecal baclofen (ITB) trial. His sitting balance im-
proved significantly, and spasticity was reduced during the
trial, but pump placement was delayed secondary to child
custody issues. Two years later, the patient underwent ITB
pump placement. He transferred to inpatient rehabilitation 1
day after pump implantation for dose adjustments and therapy.
Setting: Outpatient/inpatient rehabilitation center.
Results: Three days after pump placement, improvements
in spasticity and dysphagia were evident. The patient was
able to purposefully activate switches, make choices, and
“give me 5.” He was also vocalizing, prompting a request for
an MBS. The MBS showed improvements in swallowing;
therefore, his diet was advanced from nothing by mouth to
pureed solids and thin liquids. Functional Independence
Measure (FIM) scores also reflected a change in social inter-
action, memory, and problem solving. FIM scores advanced
from total assistance (1) to supervision (5)/modified inde-
pendent (6) in these areas.
Discussion: This case illustrates that ITB not only reduced
spasticity, but also resulted in functional improvements in
swallowing and in communication as measured by MBS and
FIM scores.
Conclusions: ITB can result in functional improvements.
Further research is warranted to determine if ITB can help
other CP patients with dysphagia.
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